@prefix np: . @prefix npx: . @prefix ns1: . @prefix ns2: . @prefix ns3: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { ns3:modifying . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" . sub:_version prov:value "2"^^xsd:integer . sub:assertion prov:generatedAtTime "2023-07-20T09:47:08.940397"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377; prov:wasDerivedFrom . rdf:OBJECT rdfs:label "anti-rheumatic drugs ( DMARDs )" . rdf:OBJECT-POSITION rdfs:label "(53, 60)" . rdf:PREDICATE rdfs:label "modifying" . rdf:PREDICATE-POSITION rdfs:label "61, 70" . rdf:SUBJECT rdfs:label "disease" . rdf:SUBJECT-POSITION rdfs:label "(53, 60)" . rdf:Statement rdfs:label "The pharmacotherapy of Takayasu arteritis (TAK) with disease-modifying anti-rheumatic drugs (DMARDs) is an evolving area." . rdfs:ABSTRACT-UID ns2:50 "fcy3fn4c" . rdfs:TRIPLE-UID ns1:fcy3fn4c-TRIPLE-ABSTRACT-1 "fcy3fn4c-TRIPLE-ABSTRACT-1" . rdfs:label "disease" . rdfs:label "dmards" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }